Exos Asset Management’s AdaptHealth AHCO Stock Holding History

Exos Asset Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,697	Closed	-$348K	–	468
2021 Q2	$348K	Sell	12,697 -7,615	-37%	-$217K	0.18%	174
2021 Q1	$747K	Buy	+20,312	New	+$717K	0.59%	35

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Exos Asset Management's AHCO Position: Q3 2021 in Review

Exos Asset Management sold out of AdaptHealth (AHCO) in Q3 2021, closing a stake of 12,697 shares — an estimated $348K sold.

Exos Asset Management first reported a position in AHCO in Q1 2021 and held it in 2 quarters. The position peaked at $747K in Q1 2021. 142 funds tracked by Wall St. Rank hold AHCO as of Q3 2021.

Exos Asset Management reported no remaining AdaptHealth position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 12,697 AdaptHealth shares in Q3 2021, an estimated $348K.
Exos Asset Management first reported a position in AdaptHealth in Q1 2021 and held it in 2 quarters.
Exos Asset Management's AdaptHealth position peaked at $747K in Q1 2021.
142 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.